A Single-Arm Exploratory Study of Enlansibumab Sequentially Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

NCT06981858 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

LOCALLY ADVANCED CERVICAL CANCERS

Interventions

DRUG: Enlonstobart Injection

Sponsor

Chongqing University Cancer Hospital